US FDA, Medtech Industry Take 'First Step' In Aligning Post-Market Risk Management
This article was originally published in SRA
Executive Summary
US-based standards organization AAMI and the Food and Drug Administration have agreed on a set of key principles to guide the post-market risk management of medical devices1.